Articles from Nachawati Law Group

Attorneys representing thousands of cancer victims criticized Bayer today for what they describe as an attempt to pressure courts, lawmakers and the public by threatening to pull its popular Roundup weedkiller from the market amid ongoing litigation.

Nachawati Law Group is proud to announce that two of the firm’s partners have earned repeat placement on the 2024 edition of D Magazine’s Best Lawyers in Dallas.

A three-judge panel of the Texas 14th Court of Appeals in Houston has unanimously ruled that Winter Storm Uri-related lawsuits against Texas electric transmission and distribution utilities (TDUs) can move forward to trial.

Dallas-based Nachawati Law Group is pleased to announce that partner Erin Wood has earned a place on the 2024 edition of Texas Rising Stars, a distinguished list of the state’s top young attorneys published by Thomson Reuters, as part of its Super Lawyers process.

Dallas-based Nachawati Law Group is pleased to announce that founding partner Majed Nachawati has earned placement on Lawdragon’s 500 Leading Plaintiff Consumer Lawyers guide for 2024. The prestigious listing highlights the top plaintiffs lawyers in the nation.

Another jury has found Bayer Monsanto’s Roundup weedkiller liable for causing non-Hodgkin lymphoma, prompting attorneys representing thousands of victims to demand that the company take responsibility for continuing to sell its poisonous product following documented cases of cancer tied to glyphosate exposure.

Attorneys representing thousands of cancer victims vowed to press on with litigation against Johnson & Johnson (NYSE: JNJ) after a federal judge rejected for a second time a proposed settlement of claims that J&J’s talc-based products cause cancer.

Nachawati Law Group is expanding its public entity representation and mass torts practice groups with the addition of veteran trial lawyer and former Nebraska Assistant Attorney General Phil Carlson.

Lawyers representing tens of thousands of plaintiffs have successfully reached resolution with Johnson & Johnson (NYSE: JNJ) after years of the pharmaceutical giant scheming to avoid responsibility for its cancer-causing talcum powder products.